Fundraising Fox
Janwillem Naesens
InvestorManaging Partner, Oncology & Droia Group at Droia Ventures
Find your path to Janwillem
Sign up to see every warm intro you have to Janwillem
- Paths you didn't know you had: your email and LinkedIn already hold routes to Janwillem. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Partner focused on oncology, representing Wepaven BV. Holds an engineering M.Sc. from University of Leuven and an INSEAD MBA; formerly at McKinsey & Company and Waterland Private Equity.
Contact· self-published, not guessed
Deals · 1
Ambagon TherapeuticsBoard seat
via Droia Ventures · filed Dec 2021 · $5.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Droia Ventures
Frequently asked questions
- Who is Janwillem Naesens?
- Managing Partner focused on oncology, representing Wepaven BV. Holds an engineering M.Sc. from University of Leuven and an INSEAD MBA; formerly at McKinsey & Company and Waterland Private Equity.
- Where does Janwillem Naesens work?
- Janwillem Naesens is Managing Partner, Oncology & Droia Group at Droia Ventures.
- What boards does Janwillem Naesens sit on?
- Janwillem Naesens holds tracked board seats at Ambagon Therapeutics, HYKU Biosciences.
About this profile. Compiled from public sources — Droia Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights